Organicell Regenerative Medicine, Inc. logo

Organicell Regenerative Medicine, Inc.


Overview | Financials
Company Name Organicell Regenerative Medicine, Inc.
Symbol OCEL
Currency USD
Price 0.007
Market Cap 10,051,230
Dividend Yield 0%
52-week-range 0.005 - 0.052
Industry Biotechnology
Sector Healthcare
CEO Dr. Harry L. Leider FACPE, M.B.A., M.D., MBA

An error occurred while fetching data.

About Organicell Regenerative Medicine, Inc.

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any

Related Stocks

Cell Source, Inc. logo

Cell Source, Inc.


0.498 USD

Provectus Biopharmaceuticals, Inc. logo

Provectus Biopharmaceuticals, Inc.


0.149 USD

Vext Science, Inc. logo

Vext Science, Inc.


0.215 USD

Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc.


0.98 USD


Numbers are in millions USD

Numbers are in millions USD